Hi,
I appreciate that you have chosen icliniq.com for your medical needs.
I am here to give you the best care possible.
I understand your concern. Major depressive disorder (MDD) is a prevalent and debilitating mental health condition impacting millions globally. Despite various treatment options available, achieving remission can be challenging, particularly for individuals with treatment-resistant depression (TRD). In recent years, transcranial magnetic stimulation (TMS) has emerged as a promising non-invasive treatment intervention for MDD, offering a potentially valuable addition to the therapeutic armamentarium. The mechanism of action involves TMS utilizes magnetic fields to induce electrical currents in targeted brain regions, specifically the left dorsolateral prefrontal cortex (DLPFC) for MDD. This stimulation modulates neuronal activity, promoting neuroplasticity and restoring the brain's functional balance. Benefits of TMS include:
- Non-invasive: No surgery or anesthesia required, minimizing potential complications.
- Well-tolerated: Fewer side effects compared to conventional antidepressant medications.
- Effective for TRD: Proven efficacy in individuals who have not responded adequately to prior medication trials.
- Durable effects: Treatment benefits can last for several months after completing the treatment course.
- Minimal cognitive impairment: Unlike some medications, TMS does not negatively impact cognitive function.
Potential risks and considerations are mentioned below:
- Mild side effects: The most commonly reported side effects include scalp discomfort, headache, and tingling sensation at the stimulation site. These are typically transient and resolve spontaneously.
- Rare risks: While uncommon, seizures and hearing problems (with inadequate ear protection) have been reported.
- Contraindications: Certain medical conditions, such as epilepsy and implanted metallic devices, preclude individuals from receiving TMS treatment.
- Cost and accessibility: TMS may be more expensive compared to some medications, and access to treatment may be limited in certain regions.
I hope your query got resolved. For further queries, you can consult me at icliniq.
Thank you.